Adam Havey, EVP, Biodefense Divison at Emergent BioSolutions Inc. (EBS), sold 8,718 shares at $33.96 ($296K) on 2016-03-14, disclosed to the SEC on 2016-03-16.
Seasonal sale ($296k) by EVP, Biodefense Divison — this insider has traded EBS in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.96 | 1,658 | $56K | 19.0% |
| 2 | $33.96 | 1,658 | $56K | 19.0% |
| 3 | $33.96 | 2,701 | $92K | 31.0% |
| 4 | $33.96 | 2,701 | $92K | 31.0% |
| Total | $33.96 avg | 8,718 | $296K | 100% |
| Filing → |
| EBS | SELL | 2020-04-08 | $478K | — | Filing → |
| EBS | SELL | 2019-03-13 | $277K | — | Filing → |
| EBS | SELL | 2019-03-04 | $354K | — | Filing → |